Darbepoetin Alfa 25mcg/0.42mL Injection

Darbepoetin Alfa 25mcg/0.42mL is a long-acting erythropoiesis-stimulating medicine used for anaemia associated with chronic kidney disease and selected chemotherapy-related anaemia. It increases red-cell production over time rather than providing immediate correction.
It is administered under the skin or into a vein according to the kidney or chemotherapy treatment schedule. Keep prefilled syringes refrigerated, do not shake them and allow the syringe to reach room temperature naturally before administration.
Darbepoetin activates erythropoietin receptors in the bone marrow, encouraging red-cell precursors to mature into circulating red blood cells.
Raised blood pressure, headache and injection-site discomfort may occur. Blood clots and, rarely, severe allergic reactions or loss of red-cell production are serious risks.
Haemoglobin, blood pressure and iron availability are monitored. Increasing haemoglobin too rapidly or to an unnecessarily high level can raise cardiovascular risk.
Can improve haemoglobin and reduce the need for red-cell transfusions when used in an appropriate anaemia treatment plan.
A response usually develops over several weeks, so it does not replace a transfusion when anaemia requires urgent correction.
Making additional red cells uses iron. Low available iron can limit the response even when the darbepoetin dose is adequate.
No. Bleeding, vitamin deficiencies, haemolysis and other marrow problems need their own treatment.
The aim is sufficient anaemia control with the lowest effective exposure, rather than pushing haemoglobin back to a high normal value.
Erythropoiesis: production of red blood cells. Haemoglobin: the oxygen-carrying protein in red cells. Erythropoietin receptor: the receptor that signals red-cell production. Transfusion: administration of donated blood components.; AR: Darbepoetin Alfa 25mcg/0.42mL حقن; FR: Darbepoetin Alfa 25mcg/0.42mL injection; PT: Darbepoetin Alfa 25mcg/0.42mL injeção; ES: Darbepoetin Alfa 25mcg/0.42mL inyección; RU: Darbepoetin Alfa 25mcg/0.42mL инъекция; ID: Darbepoetin Alfa 25mcg/0.42mL suntikan; VI: Darbepoetin Alfa 25mcg/0.42mL thuốc tiêm; MS: Darbepoetin Alfa 25mcg/0.42mL suntikan; TL: Darbepoetin Alfa 25mcg/0.42mL iniksyon; ZH-SG: Darbepoetin Alfa 25mcg/0.42mL 注射剂
International B2B Enquiry
Send a structured B2B enquiry for Darbepoetin Alfa 25mcg/0.42mL Injection under Blood Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Darbepoetin Alfa 25mcg/0.42mL Injection